Dangers in the practice of defensive medicine in hemostasis testing for investigation of bleeding or thrombosis: Part i - Routine coagulation testing

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 7, 2014, Pages 812-824

  Lippi, Giuseppe ^a,d   Favaloro, Emmanuel J ^b   Franchini, Massimo ^c  

^a UO Diagnostica Ematochimica   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c CARLO POMA HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

activated partial thromboplastin time; D dimer; defensive medicine; inappropriateness; prothrombin time

Indexed keywords

D DIMER;

ARTICLE; AWARENESS; BLEEDING; BLOOD CLOTTING TEST; CONTROLLED STUDY; DEFENSIVE MEDICINE; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH CARE; HEMOSTASIS; HUMAN; LABORATORY TEST; MALPRACTICE; MEDICAL LIABILITY; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOSIS; BLOOD; PHYSIOLOGIC MONITORING; RISK FACTOR;

BLOOD COAGULATION TESTS; DEFENSIVE MEDICINE; HEMORRHAGE; HEMOSTASIS; HUMANS; MONITORING, PHYSIOLOGIC; RISK FACTORS; THROMBOSIS;

EID: 84923083545     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1394108     Document Type: Article

References (96)

1. Passmore K., Leung W-C. Defensive practice among psychiatrists: a questionnaire survey. Postgrad Med J: 2002; 78 925 671 673
2. Studdert D. M., Mello M. M., Sage W. M., et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA: 2005; 293 21 2609 2617
3. Sloan F. A., Shadle J. H. Is there empirical evidence for Defensive Medicine? A reassessment. J Health Econ: 2009; 28 2 481 491
4. Studdert D. M., Mello M. M., Gawande A. A., et al. Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med: 2006; 354 19 2024 2033
5. Kessler D., McClellan M. Do doctors practice defensive medicine? Q J Econ: 1996; 111 353 390
6. Kessler D., McClellan M. Malpractice law and health care reform: optimal liability policy in an era of managed care. J Public Econ: 2002; 84 175 197
7. Lippi G., Plebani M. Biomarker research and leading causes of death worldwide: a rather feeble relationship. Clin Chem Lab Med: 2013; 51 9 1691 1693
8. Lippi G., Mattiuzzi C. Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics. Clin Chem Lab Med: 2013; 51 2 243 245
9. Lippi G., Plebani M. False myths and legends in laboratory diagnostics. Clin Chem Lab Med: 2013; 51 11 2087 2097
10. DeKay M. L., Asch D. A. Is the defensive use of diagnostic tests good for patients, or bad? Med Decis Making: 1998; 18 1 19 28
11. Lippi G., Cervellin G., Plebani M. The ten commandments of laboratory testing for emergency physicians. Clin Chem Lab Med: 2014; 52 2 183 187
12. Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline-Third Edition. CLSI document C28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
13. Lippi G., Franchini M., Cervellin G. Diagnosis and management of ischemic heart disease. Semin Thromb Hemost: 2013; 39 2 202 213
14. Lakos G., Favaloro E. J., Harris E. N., et al. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum: 2012; 64 1 1 10
15. Rang M. The Ulysses syndrome. Can Med Assoc J: 1972; 106 2 122 123
16. Korenstein D., Falk R., Howell E. A., Bishop T., Keyhani S. Overuse of health care services in the United States: an understudied problem. Arch Intern Med: 2012; 172 2 171 178
17. Zhi M., Ding E. L., Theisen-Toupal J., Whelan J., Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS ONE: 2013; 8 11 e78962
18. Summerton N. Positive and negative factors in defensive medicine: a questionnaire study of general practitioners. BMJ: 1995; 310 6971 27 29
19. Van Boven K., Dijksterhuis P., Lamberts H. Defensive testing in Dutch family practice. Is the grass greener on the other side of the ocean? J Fam Pract: 1997; 44 5 468 472
20. Collins M. F., Kneeland M. D., Campion F. X., et al. Massachusetts Risk Management Survey (MaRMS) of teaching hospital physicians. J Healthc Risk Manag: 1997; 17 2 3 11
21. Hiyama T., Yoshihara M., Tanaka S., et al. Defensive medicine practices among gastroenterologists in Japan. World J Gastroenterol: 2006; 12 47 7671 7675
22. Nahed B. V., Babu M. A., Smith T. R., Heary R. F. Malpractice liability and defensive medicine: a national survey of neurosurgeons. PLoS ONE: 2012; 7 6 e39237
23. Sathiyakumar V., Jahangir A. A., Mir H. R., et al. The prevalence and costs of defensive medicine among orthopaedic trauma surgeons: a national survey study. J Orthop Trauma: 2013; 27 10 592 597
24. Quick A. J. The thromboplastin reagent for the determination of prothrombin. Science: 1940; 92 2379 113 114
25. Hood J. L., Eby C. S. Evaluation of a prolonged prothrombin time. Clin Chem: 2008; 54 4 765 768, discussion 768-769
26. Lippi G., Plebani M., Favaloro E. J. Technological advances in the hemostasis laboratory. Semin Thromb Hemost: 2014; 40 2 178 185
27. Favaloro E. J., Lippi G., Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology: 2011; 43 7 682 692
28. Franchini M. Haemostasis and pregnancy. Thromb Haemost: 2006; 95 3 401 413
29. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol: 2006; 60 2 144 151
30. Lippi G., Maffulli N. Biological influence of physical exercise on hemostasis. Semin Thromb Hemost: 2009; 35 3 269 276
31. Vescovi P. P., Favaloro E. J., Lippi G., et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin Thromb Hemost: 2011; 37 1 7 10
32. Franchini M., Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Hemost: 2010; 36 5 485 492
33. Kamal A. H., Tefferi A., Pruthi R. K. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc: 2007; 82 7 864 873
34. Peterson C. E., Kwaan H. C. Current concepts of warfarin therapy. Arch Intern Med: 1986; 146 3 581 584
35. Lippi G., Becan-McBride K., Behúlová D., et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med: 2013; 51 1 229 241
36. Lippi G., Salvagno G. L., Montagnana M., Lima-Oliveira G., Guidi G. C., Favaloro E. J. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost: 2012; 38 6 565 575
37. Adcock Funk D. M., Lippi G., Favaloro E. J. Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost: 2012; 38 6 576 585
38. Lippi G., Salvagno G. L., Montagnana M., Guidi G. C. Short-term venous stasis influences routine coagulation testing. Blood Coagul Fibrinolysis: 2005; 16 6 453 458
39. Lippi G., Ippolito L., Favaloro E. J. Technical evaluation of the novel preanalytical module on instrumentation laboratory ACL TOP: advancing automation in hemostasis testing. J Lab Autom: 2013; 18 5 382 390
40. Lippi G., Rossi R., Ippolito L., et al. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples. Semin Thromb Hemost: 2013; 39 7 834 839
41. Da Rin G., Lippi G. Total laboratory automation of routine hemostasis testing. J Lab Autom: 2013; 19 4 419 422
42. Da Rin G., Lippi G. Sample rerun after short-term refrigerated storage: impact on routine coagulation testing. Int J Lab Hematol: 2014; 36 5 e71 e73
43. Lippi G., Montagnana M., Salvagno G. L., Guidi G. C. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med: 2006; 130 2 181 184
44. Daves M., Giacomuzzi K., Tagnin E., et al. Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma. Blood Coagul Fibrinolysis: 2014; 25 3 292 295
45. Lima-Oliveira G., Lippi G., Salvagno G. L., Montagnana M., Picheth G., Guidi G. C. Sodium citrate vacuum tubes validation: preventing preanalytical variability in routine coagulation testing. Blood Coagul Fibrinolysis: 2013; 24 3 252 255
46. Lippi G., Plebani M. Primary blood tubes mixing: time for updated recommendations. Clin Chem Lab Med: 2012; 50 4 599 600
47. Chuang J., Sadler M. A., Witt D. M. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes. Chest: 2004; 126 4 1262 1266
48. Lippi G., Salvagno G. L., Montagnana M., Guidi G. C. Influence of primary sample mixing on routine coagulation testing. Blood Coagul Fibrinolysis: 2007; 18 7 709 711
49. Parenmark A., Landberg E. To mix or not to mix venous blood samples collected in vacuum tubes? Clin Chem Lab Med: 2011; 49 12 2061 2063
50. Lima-Oliveira G., Lippi G., Salvagno G. L., et al. Processing of diagnostic blood specimens: is it really necessary to mix primary blood tubes after collection with evacuated tube system? Biopreserv Biobank: 2014; 12 1 53 59
51. Lippi G., Favaloro E. J. Activated partial thromboplastin time: new tricks for an old dogma. Semin Thromb Hemost: 2008; 34 7 604 611
52. Bonar R. A., Favaloro E. J., Marsden K. External quality assurance for heparin monitoring. Semin Thromb Hemost: 2012; 38 6 632 639
53. Lippi G., Ardissino D., Quintavalla R., Cervellin G. Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests. J Thromb Thrombolysis: 2014; 38 2 269 274
54. Liu J., Yuan E., Lee L. Gestational age-specific reference intervals for routine haemostatic assays during normal pregnancy. Clin Chim Acta: 2012; 413 1-2 258 261
55. Lippi G., Meschi T., Borghi L. Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical implications. Blood Coagul Fibrinolysis: 2012; 23 2 177 178
56. Lippi G., Franchini M., Brazzarola P., Manzato F. Preoperative screening: the rationale of measuring APTT in risk assessment. Haematologica: 2001; 86 3 328
57. Renné T., Schmaier A. H., Nickel K. F., Blombäck M., Maas C. In vivo roles of factor XII. Blood: 2012; 120 22 4296 4303
58. Lippi G., Salvagno G. L., Ippolito L., Franchini M., Favaloro E. J. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis: 2010; 21 5 459 463
59. Lippi G., Franchini M., Targher G., et al. Epidemiological association between fasting plasma glucose and shortened APTT. Clin Biochem: 2009; 42 1-2 118 120
60. Lippi G., Targher G., Favaloro E. J., Franchini M. Venous thromboembolism in chronic liver disease. Semin Thromb Hemost: 2011; 37 1 66 76
61. Mielicki W. P., Tenderenda M., Rutkowski P., Chojnowski K. Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients. Cancer Lett: 1999; 146 1 61 66
62. Mina A., Favaloro E. J., Mohammed S., Koutts J. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagul Fibrinolysis: 2010; 21 2 152 157
63. van Veen J. J., Spahn D. R., Makris M. Routine preoperative coagulation tests: an outdated practice? Br J Anaesth: 2011; 106 1 1 3
64. Telgt D. S., Macik B. G., McCord D. M., Monroe D. M., Roberts H. R. Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor. Thromb Res: 1989; 56 5 603 609
65. Mina A., Favaloro E. J., Koutts J. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity. Blood Coagul Fibrinolysis: 2012; 23 3 203 207
66. Favaloro E. J. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost: 2010; 36 4 458 467
67. Lippi G., Favaloro E. J. Laboratory hemostasis: milestones in clinical chemistry and laboratory medicine. Clin Chem Lab Med: 2013; 51 1 91 97
68. Lima-Oliveira G., Lippi G., Salvagno G. L., et al. Effects of vigorous mixing of blood vacuum tubes on laboratory test results. Clin Biochem: 2013; 46 3 250 254
69. Salvagno G. L., Lippi G., Montagnana M., Franchini M., Poli G., Guidi G. C. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol: 2009; 31 4 462 467
70. Franchini M., Mannucci P. M. The history of hemophilia. Semin Thromb Hemost: 2014; 40 5 571 576
71. Favaloro E. J. Trials and tribulations in lupus anticoagulant testing. Clin Chem Lab Med: 2013; 51 2 253 256
72. Favaloro E. J., Wong R. C. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology: 2014; 46 6 481 495
73. Lippi G., Franchini M., Targher G., Favaloro E. J. Help me, Doctor! My D-dimer is raised. Ann Med: 2008; 40 8 594 605
74. Lippi G., Cervellin G., Casagranda I., Morelli B., Testa S., Tripodi A. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med: 2014; 52 5 621 628
75. Bates S. M. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost: 2012; 38 7 673 682
76. Danese E., Montagnana M., Cervellin G., Lippi G. Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence. Ann Med: 2014; 46 6 364 371
77. Cervellin G., Bonfanti L., Picanza A., Lippi G. Relation of D-dimer and troponin I in patients with new-onset atrial fibrillation. Am J Cardiol: 2014; 114 7 1129 1130
78. Bergmann F., Pingel N., Czwalinna A., Koch M. D-Dimer in normal pregnancy: determination of reference values for three commercially available assays. Clin Chem Lab Med: 2014; (e-pub ahead of print). doi: 10.1515/cclm-2014-0054
79. Lippi G., Bonfanti L., Saccenti C., Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med: 2014; 25 1 45 48
80. Lippi G., Favaloro E. J., Cervellin G. A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age. Semin Thromb Hemost: 2014; (e-pub ahead of print). doi: 10.1055/s-0034-1384630
81. Knecht M. F., Heinrich F., Spanuth E. Evaluation of plasma D-dimer in the diagnosis and in the course of fibrinolytic therapy of deep vein thrombosis and pulmonary embolism. Thromb Res: 1992; 67 2 213 220
82. Lippi G., Veraldi G. F., Fraccaroli M., Manzato F., Cordiano C., Guidi G. Variation of plasma D-dimer following surgery: implications for prediction of postoperative venous thromboembolism. Clin Exp Med: 2001; 1 3 161 164
83. Lippi G., Favaloro E. J. D-dimer measurement and laboratory feedback. J Emerg Med: 2009; 37 1 82 83, author reply 83
84. Lippi G., Ippolito L., Tondelli M. T., Favaloro E. J. Interference from heterophilic antibodies in D-dimer assessment. A case report. Blood Coagul Fibrinolysis: 2014; 25 3 277 279
85. Robier C., Edler E., Klescher D., Neubauer M. False-positive D-dimer result in a latex-enhanced immunoassay caused by interfering human anti-mouse antibodies. Clin Chem Lab Med: 2014; (e-pub ahead of print). doi: 10.1515/cclm-2014-0496
86. Lippi G., Avanzini P., Zobbi V., Ippolito L. Influence of mechanical hemolysis of blood on two D-dimer immunoassays. Blood Coagul Fibrinolysis: 2012; 23 5 461 463
87. Earls J. P., White R. D., Woodard P. K., et al. ACR Appropriateness Criteria® chronic chest pain-high probability of coronary artery disease. J Am Coll Radiol: 2011; 8 10 679 686
88. Jackson B. R. The dangers of false-positive and false-negative test results: false-positive results as a function of pretest probability. Clin Lab Med: 2008; 28 2 305 319, vii
89. Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost: 2014; 40 1 106 114
90. Verstappen W. H., van der Weijden T., Sijbrandij J., et al. Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trial. JAMA: 2003; 289 18 2407 2412
91. Miyakis S., Karamanof G., Liontos M., Mountokalakis T. D. Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy. Postgrad Med J: 2006; 82 974 823 829
92. Feldman L. S., Shihab H. M., Thiemann D., et al. Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med: 2013; 173 10 903 908
93. Chu K. H., Wagholikar A. S., Greenslade J. H., O'Dwyer J. A., Brown A. F. Sustained reductions in emergency department laboratory test orders: impact of a simple intervention. Postgrad Med J: 2013; 89 1056 566 571
94. Lippi G., Cervellin G., Plebani M. Less is more, but do not throw out the baby with the bathwater either! Diagnosis: 2014; 1 3 199 201
95. Kottke-Marchant K. Algorithmic approaches to hemostasis testing. Semin Thromb Hemost: 2014; 40 2 195 204
96. Cervellin G., Borghi L., Lippi G. Do clinicians decide relying primarily on Bayesians principles or on Gestalt perception inmedicine. Intern Emerg Med 2014; 9(5):513-519